Serum folate and methylenetetrahydrofolate reducatase (MTHFR) C677T polymorphism adjusted for folate intake

Journal of Epidemiology

Volumn 18, Issue 3, 2008, Pages 125-131

  Nishio, Kazuko ^a,b   Goto, Yasuyuki ^a   Kondo, Takaaki ^c   Ito, Shimon ^a   Ishida, Yoshiko ^a   Kawai, Sayo ^a   Naito, Mariko ^a   Wakai, Kenji ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Eating; Folic acid; Japanese; MTHFR C677T

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD; CONFIDENCE INTERVAL; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HELICOBACTER INFECTION; HUMAN; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADULT; AGED; ALGORITHMS; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; FEMALE; FOLIC ACID; GENOTYPE; HELICOBACTER INFECTIONS; HUMANS; JAPAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; VITAMIN B COMPLEX;

EID: 45749128731     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE2007417     Document Type: Article

References (51)

1. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316: 894-8.
2. 6 on progression of sub-clinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2000; 355: 517-22.
3. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001; 161: 695-700.
4. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
5. Czeizel E, Dudás I. Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orv Hetil 1994; 135: 2313-7 (in Hungarian).
6. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-83.
7. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202.
8. Boushey CJ, Beresford SA, Omenn GS, Motutsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
9. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-50.
10. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Indian Heart J 2000; 52: S18-26.
11. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000; 130: 129-32.
12. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997; 350: 1666-9.
13. Wild J, Sutcliffe M, Schorah CJ, Levene MI. Prevention of neural-tube defects. Lancet 1997; 350: 30-1.
14. United States Food and Drug Administration. Foods Standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996; 61: 8781-97.
15. Health Canada. Food and drug regulations, Amendment Schedule no. 1066. Ottawa: Health Canada; 1997.
16. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981-6.
17. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002; 360: 2047-8.
18. Savage DG, Lindenbaum J. Folate-cobalamin interactions. In: Bailey LB, editors. Folate in health and disease. New York: Marcel Dekker; 1995. p. 237-85.
19. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007; 16: 1325-9.
20. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297: 2351-9.
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
22. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003; 40: 619-25.
23. Lwin H, Yokoyama T, Date C, Yoshiike N, Kokubo Y, Tanaka H. Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677T MTHFR)? A cross-sectional study in a Japanese rural population. J Epidermol 2002; 12: 126-35.
24. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
25. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-6.
26. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998; 128: 1336-41.
27. Harmon DL, Woodside JV, Yarnell JW, McMaster D, Young IS, McCrum EE, et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 1996; 89: 571-7.
28. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000; 46: 1065-71.
29. Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM Jr, et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94: 3074-8.
30. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997; 96: 412-7.
31. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999; 99: 2383-8.
32. Takahashi K, Yoshimura Y, Sekimoto, T, Kunii D, Komatsu R, Yamamoto S. Making the food frequency questionnaire based on food group frequency based on food group for intake investigation according to nutrient and food group and validity. Eiyougaku Zasshi 2001, 59: 221-32 (in Japanese).
33. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000; 91: 865-8.
34. Brown CC, Kipnis V, Freedman LS, Hartman AM, Schatzkin A, Wacholder S. Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol 1994; 139: 323-8.
35. de Bree A, Verschuren WM, Björke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, et al. Effect of the meth-lenetetrahydrofolate reductase. 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003; 77: 687-93.
36. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 2002; 111: 299-302.
37. Hiraoka M. Folate intake, serum folate, serum total homocysteine levels and methylenetetrahydrofolate reductase C677T polymorphism in young Japanese women. J Nutr Sci Vitaminol (Tokyo) 2004; 50: 238-45.
38. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clint Nutr 1997; 65: 1220S-8S.
39. Hiraoka M, Kato K, Saito Y, Yasuda K, Kagawa Y. Gene-nutrient and gene-gene interactions of controlled folate intake by Japaneae women. Biochem Biophys Res Commun 2004; 316: 1210-6.
40. Hamajima N, Saito T, Matsuo K, Suzuki T, Nakamura T, Matsuura A, et al. Genotype frequencies of 50 polymorphisms for 24l Japanese non-cancer patients. J Epidemiol 2002; 12: 229-36.
41. Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, et al. Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet 2005; 50: 241-8.
42. Baker H, Jaslow SP, Frank O. Severe impairment of dietary, folate utilization in the elderly. J Am Geriatr Soc 1978; 26: 218-21.
43. Tamura T, Stokstad EL. The availability of food folate in man: Br J Haematol 1973; 25: 513-32.
44. Colman N, Green R, Metz J. Prevention of folate deficiency by food fortification. II. Absorption of folic acid from fortified staple foods. Am J Clin Nutr 1975; 28: 459-64.
45. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987; 46: 1016-28.
46. Prinz-Langenohl R, Bronstrup A, Thorand B, Hages M, Pietrzik K. Availability of food folate in humans. J Nutr 1999; 129: 913-6.
47. Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 1999; 129: 1135-9.
48. McNulty H. Increasing evidence in favour of mandatory fortification with folic acid. Br J Nutr 2001; 86: 425-6.
49. 12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.
50. Pfeiffer CM, Rogers LM, Bailey LB, Gregory JF 3rd. Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am J Clin Nutr 1997; 66: 1388-97.
51. 12 among Japanese adults in two rural communities from 1974 through 2001. J Epidemiol 2005; 15: 29-37.